SCHEMBL6529018

SCHEMBL6529018

COC(Cc1ccc(OCCCOc2ccc(NC(=O)c3ccc(Cl)cc3)cc2)cc1)C(=O)O

nearest known ligand 0.62

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PPARG P37231 10/20 0.62
PPARA Q07869 10/20 0.62
PPARD Q03181 8/20 0.62
KMT2A Q03164 5/20 0.50
MEN1 O00255 4/20 0.50
NPC1 O15118 2/20 0.47
POLB P06746 1/20 0.47
RAB9A P51151 1/20 0.47
SENP8 Q96LD8 1/20 0.47
SENP7 Q9BQF6 1/20 0.47
SENP6 Q9GZR1 1/20 0.47
MAPT P10636 1/20 0.46
LMNA P02545 1/20 0.46
STAT3 P40763 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
KDM4E B2RXH2 1/20 0.46
ALDH1A1 P00352 1/20 0.46
CYP1A2 P05177 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5395118 1.00 PPARG (0.62) PPARGPPARAPPARDKMT2AMEN1
SCHEMBL5385227 0.91 PPARG (0.65) PPARGPPARAPPARDNPC1POLB
SCHEMBL5374720 0.89 PPARG (0.62) PPARGPPARAPPARDKMT2AMEN1
SCHEMBL5375428 0.85 PPARA (0.61) PPARGPPARAPPARDMAPT
SCHEMBL5386189 0.84 PPARA (0.81) PPARGPPARAPPARD
SCHEMBL5385663 0.83 PPARG (0.62) PPARGPPARAPPARDNPC1RAB9A
SCHEMBL6575710 0.83 PPARG (0.62) PPARGPPARAPPARDNPC1RAB9A
SCHEMBL5395103 0.82 PPARG (0.62) PPARGPPARAPPARDKMT2AMEN1
SCHEMBL5381113 0.82 PPARG (0.62) PPARGPPARAPPARDKMT2AMEN1
SCHEMBL5383401 0.82 PPARG (0.61) PPARGPPARAPPARDKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050020684-A1 Modulators of peroxisome proliferator activated receptors ELI LILLY AND COMPANY 2005-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050020684-A1 Modulators of peroxisome proliferator activated receptors NCOA4, PPARG, PPARA PPARG 2/4885PPARA 3/4885PPARD 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.